{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:40:16Z","timestamp":1784806816622,"version":"3.55.0"},"reference-count":35,"publisher":"BMJ","issue":"12","funder":[{"name":"Joint Action CanCon as part of the Health Programme of the European Union"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,10,17]]},"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To review evidence-based (EB) recommendations on survivorship care for primary care providers (PCPs) in EB breast cancer guidelines.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design and setting<\/jats:title>\n                  <jats:p>Guidelines were collected via experts and via literature database, guideline database and cancer agency websites searches.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>EB guidelines in any language published between 2012 and 2017 were collected. EB recommendations on survivorship care relevant for PCPs were extracted and grouped into three categories (recurrence detection, long-term effects and recurrence prevention). The content of the recommendations was analysed and summarised in the number and type of clinical topics addressed. The Appraisal of Guidelines for Research and Evaluation II instrument was used to evaluate the methodological quality of the guidelines.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Six guidelines, of which two were of acceptable methodological quality, were included. One was specifically made for general practitioners. Fifteen clinical topics were identified. Guidelines differed in the clinical topics addressed and for some identical topics in the content of the recommendations. Many recommendations were based on low-quality evidence. Recurrence detection received most attention, physical examination and mammography were often highlighted. Potential complications largely varied in number and type. Intimacy concerns, vaginal dryness, dyspareunia, fatigue, menopausal symptoms, peripheral neuropathy and lymphedema were reported in more than one guideline. Recurrence prevention was mentioned in four guidelines; all recommended physical activity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The number of EB recommendations in guidelines is limited. Moreover, recommendations differ between guidelines and most are based on low-quality evidence. More high-quality research is needed to develop and adapt guidelines to support PCPs in providing optimal breast cancer survivorship care.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2016-015118","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T00:35:14Z","timestamp":1513125314000},"page":"e015118","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":22,"title":["Evidence-based recommendations on care for breast cancer survivors for primary care providers: a review of evidence-based breast cancer guidelines"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9571-576X","authenticated-orcid":false,"given":"Inge","family":"Spronk","sequence":"first","affiliation":[{"name":"General Practice, NIVEL Netherlands Institute for Health Services Research, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke C","family":"Korevaar","sequence":"additional","affiliation":[{"name":"General Practice, NIVEL Netherlands Institute for Health Services Research, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois G","family":"Schellevis","sequence":"additional","affiliation":[{"name":"General Practice, NIVEL Netherlands Institute for Health Services Research, Utrecht, The Netherlands"},{"name":"Department of General Practice & Elderly Care Medicine, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tit","family":"Albreht","sequence":"additional","affiliation":[{"name":"Centre for Health System Analyses, National Institute of Public Health, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jako S","family":"Burgers","sequence":"additional","affiliation":[{"name":"Dutch College of General Practitioners, Utrecht, The Netherlands"},{"name":"Department Family Medicine, School CAPHRI, Maastricht University, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,12,12]]},"reference":[{"key":"2025101814141405000_7.12.e015118.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20107"},{"key":"2025101814141405000_7.12.e015118.2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-008-0023-4"},{"key":"2025101814141405000_7.12.e015118.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2005.04.015"},{"key":"2025101814141405000_7.12.e015118.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2648.2008.04927.x"},{"key":"2025101814141405000_7.12.e015118.5","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgq006"},{"key":"2025101814141405000_7.12.e015118.6","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.0934407"},{"key":"2025101814141405000_7.12.e015118.7","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp09X420220"},{"key":"2025101814141405000_7.12.e015118.8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.41.9101"},{"key":"2025101814141405000_7.12.e015118.9","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp11X561195"},{"key":"2025101814141405000_7.12.e015118.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.07.011"},{"key":"2025101814141405000_7.12.e015118.11","doi-asserted-by":"publisher","DOI":"10.2190\/PM.40.2.c"},{"key":"2025101814141405000_7.12.e015118.12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.4883"},{"key":"2025101814141405000_7.12.e015118.13","first-page":"477","article-title":"Views of primary care providers on follow-up care of cancer patients","volume":"39","author":"Nissen","year":"2007","journal-title":"Fam Med"},{"key":"2025101814141405000_7.12.e015118.14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.12.1461"},{"key":"2025101814141405000_7.12.e015118.15","unstructured":"Steinberg E , Greenfield S , Mancher M , et al . Clinical practice guidelines we can trust: National Academies Press, 2011."},{"key":"2025101814141405000_7.12.e015118.16","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.090449"},{"key":"2025101814141405000_7.12.e015118.17","doi-asserted-by":"publisher","DOI":"10.1136\/qhc.12.1.18"},{"key":"2025101814141405000_7.12.e015118.18","article-title":"The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies","volume":"19","author":"Alonso-Coello","year":"2010","journal-title":"Qual Saf Health Care"},{"key":"2025101814141405000_7.12.e015118.19","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2753.2012.01873.x","article-title":"Diagnosis of pheochromocytoma: a clinical practice guideline appraisal using AGREE II instrument","volume":"19","author":"Yan","year":"2013","journal-title":"J Eval Clin Pract"},{"key":"2025101814141405000_7.12.e015118.20","doi-asserted-by":"publisher","DOI":"10.1186\/ar2339"},{"key":"2025101814141405000_7.12.e015118.21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082986","article-title":"A systematic critical appraisal for non-pharmacological management of osteoarthritis using the appraisal of guidelines research and evaluation II instrument","volume":"9","author":"Brosseau","year":"2014","journal-title":"PLoS One"},{"key":"2025101814141405000_7.12.e015118.22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/fampra\/cmw140","article-title":"Review of guidance on recurrence risk management for general practitioners in breast cancer, colorectal cancer and melanoma guidelines","volume":"34","author":"Spronk","year":"2017","journal-title":"Fam Pract"},{"key":"2025101814141405000_7.12.e015118.23","unstructured":"Albreht T , Danova N , Dimitrov P , et al . EU policy recommendations for quality improvement in cancer after-care at the community level. 105, 2017."},{"key":"2025101814141405000_7.12.e015118.24","unstructured":"National Comprehensive Cancer Network. Breast cancer. 1st edn: National Comprehensive Cancer Network, 2015."},{"key":"2025101814141405000_7.12.e015118.25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.3809"},{"key":"2025101814141405000_7.12.e015118.26","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv298"},{"key":"2025101814141405000_7.12.e015118.27","unstructured":"Alberta Health Services. Follow-up care for early-stage breast cancer. 2nd edn. Albertha: Albertha Health Services, 2015."},{"key":"2025101814141405000_7.12.e015118.28","first-page":"556","article-title":"NHG-Standaard Borstkanker (derde herziening)","volume":"59","author":"NHG-Werkgroep Borstkanker","year":"2016","journal-title":"Huisarts Wet"},{"key":"2025101814141405000_7.12.e015118.29","unstructured":"Leitlinienprogramm Onkologie. Interdisziplin\u00e4re s3-leitlinie f\u00fcr die diagnostik, therapie und nachsorge des mammakarzinoms. langversion. 362. Berlin\u00a0: Leitlinienprogramm Onkologie der AWMF, Deutschen Krebsgesellschaft e.V. und Deutschen Krebshilfe e.V, 2012."},{"key":"2025101814141405000_7.12.e015118.30","unstructured":"Associazione Italiana di Oncologia Medica. Linee guida neoplasie della mammella. 222: Associazione Italiana di Oncologia Medica, 2016."},{"key":"2025101814141405000_7.12.e015118.31","unstructured":"National Cancer Institute. NCI dictionary of cancer terms. 2017 https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms?cdrid=693593"},{"key":"2025101814141405000_7.12.e015118.32","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00205-3"},{"key":"2025101814141405000_7.12.e015118.33","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X15598529"},{"key":"2025101814141405000_7.12.e015118.34","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp15X687409"},{"key":"2025101814141405000_7.12.e015118.35","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.06.157"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2016-015118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:14:27Z","timestamp":1760822067000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2016-015118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":35,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,12]]},"published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.1136\/bmjopen-2016-015118"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2016-015118","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}